BML-PW8840-0100

antibody from Enzo Life Sciences

Targeting: PSMB9 beta1i, LMP2, PSMB6i, RING12

Western blot (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

BML-PW8840-0100

Provider

Enzo Life Sciences

Proper citation

Enzo Life Sciences Cat#BML-PW8840-0100, RRID:AB_11178412

Product name

Proteasome 20S _1i subunit monoclonal antibody (LMP2 - 13)

Antibody type

Monoclonal

Antigen

Recombinant full length protein

Description

Protein G-affinity purified ascites.

Reactivity

Human, Rat

Host

Mouse

Isotype

IgG

Antibody clone number

LMP2-13

Vial size

100 μl

Storage

-20°C

References

Submitted references

Gene expression of catalytic proteasome subunits and resistance toward proteasome inhibition of B lymphocytes from patients with primary sjogren syndrome.

Martinez-Gamboa L, Lesemann K, Kuckelkorn U, Scheffler S, Ghannam K, Hahne M, Gaber-Elsner T, Egerer K, Naumann L, Buttgereit F, Dörner T, Kloetzel PM, Burmester GR, Faustman DL, Feist E
The Journal of rheumatology 2013 May;40(5):663-73

---

Purification and separation of the 20S immunoproteasome from the constitutive proteasome and identification of the subunits by LC-MS.

Dechavanne V, Vilbois F, Glez L, Antonsson B
Protein expression and purification 2013 Feb;87(2):100-10

---

Immunoproteasome expression is induced in mesial temporal lobe epilepsy.

Mishto M, Ligorio C, Bellavista E, Martucci M, Santoro A, Giulioni M, Marucci G, Franceschi C
Biochemical and biophysical research communications 2011 Apr 29;408(1):65-70

---

Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis.

Vasuri F, Capizzi E, Bellavista E, Mishto M, Santoro A, Fiorentino M, Capri M, Cescon M, Grazi GL, Grigioni WF, D'Errico-Grigioni A, Franceschi C
Biochemical and biophysical research communications 2010 Jun 25;397(2):301-6

---

The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition.

Bianchi G, Oliva L, Cascio P, Pengo N, Fontana F, Cerruti F, Orsi A, Pasqualetto E, Mezghrani A, Calbi V, Palladini G, Giuliani N, Anderson KC, Sitia R, Cenci S
Blood 2009 Mar 26;113(13):3040-9